A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Author: Geller Melissa A.   Cooley Sarah   Judson Patricia L.   Ghebre Rahel   Carson Linda F.   Argenta Peter A.   Jonson Amy L.   Panoskaltsis-Mortari Angela   Curtsinger Julie   McKenna David   Dusenbery Kathryn   Bliss Robin   Downs Levi S.   Miller Jeffrey S.  

Publisher: Ashgate Publishing Ltd

ISSN: 1465-3249

Source: Cytotherapy, Vol.13, Iss.1, 2011-01, pp. : 98-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract